Navigation Links
New England Journal of Medicine Publishes New Data on Gardasil,,Merck's Cervical Cancer Vaccine

. Use with Hormonal Contraceptives In clinical studies, 13,293 subjects (vaccine = 6644; placebo = 6649) who had post-Month 7 follow-up used hormonal contraceptives for a total of 17,597 person-years (65.1% of the total follow-up time in the studies). Use of hormonal contraceptives or lack of use of hormonal contraceptives among study participants did not alter vaccine efficacy in the PPE population. Use with Systemic Immunosuppressive Medications Immunosuppressive therapies, including irradiation, antimetabolites, alkylating agents, cytotoxic drugs, and corticosteroids (used in greater than physiologic doses), may reduce the immune responses to vaccines (see PRECAUTIONS, General). Carcinogenesis, Mutagenesis, Impairment of Fertility GARDASIL has not been evaluated for the potential to cause carcinogenicity or genotoxicity. GARDASIL administered to female rats at a dose of 120 mcg total protein, which corresponds to approximately 300-fold excess relative to the projected human dose, had no effects on mating performance, fertility, or embryonic/fetal survival. Pregnancy Pregnancy Category B: Reproduction studies have been performed in female rats at doses up to 300 times the human dose (on a mg/kg basis) and have revealed no evidence of impaired female fertility or harm to the fetus due to GARDASIL. However, it is not known whether GARDASIL can cause fetal harm when administered to a pregnant woman or if it can affect reproductive capacity. GARDASIL should be given to a pregnant woman only if clearly needed. An evaluation of the effect of GARDASIL on embryo-fetal, pre- and postweaning development was conducted using rats. One group of rats was administered GARDASIL twice prior to gestation, during the period of organogenesis (gestation day 6) and on lactation day 7. A second group of pregnant rats was administered GARDASIL during the period of organogenesis (gestation day 6) and on lactation day 7 only. G
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
2. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
3. Statement by Philip Home Chairman of the RECORD Study Steering Committee and Professor of Diabetes Medicine at Newcastle University in England
4. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
5. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
6. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
7. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
8. Genetics Journal Thimerosal/Autism Study the Best Science Drug Company Money Can Buy
9. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
10. Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in Journal of American College of Cardiology
11. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
Post Your Comments:
(Date:8/28/2014)... Californie, 28 août 2014 ... le début des inclusions des patients ... des dispositifs expérimentaux (ou étude « IDE » ... l,innocuité et l,efficacité du système WEB™ ... Adam Arthur , professeur agrégé, ...
(Date:8/28/2014)... Calif. , Aug. 28, 2014  Sequent ... patient enrollment in an Investigational Device Exemption ("IDE") ... of the WEB™ Aneurysm Embolization System ("WEB"). ... Tennessee Department of Neurosurgery/Semmes-Murphey Clinic and Principal Investigator ... in the study, treating them with the WEB ...
(Date:8/28/2014)... LAWRENCEVILLE, N.J. , Aug. 28, 2014  Celsion ... drug development company, today announced that Michael H. ... be presenting at the Rodman & Renshaw 16th Annual ... at 10:50 a.m. Eastern Time. The conference is being ... York City.  A copy of the presentation will be ...
Breaking Medicine Technology:Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 2Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 3Sequent Medical annonce le démarrage d'une étude IDE pour le système WEB d'embolisation des anévrismes 4Sequent Medical Announces Initiation Of IDE Study For The WEB Aneurysm Embolization System 2Sequent Medical Announces Initiation Of IDE Study For The WEB Aneurysm Embolization System 3Celsion to Present at the Rodman & Renshaw 16th Annual Healthcare Conference 2
... Oxazolidinone Enrolls in Four Months SAN DIEGO, Jan. 26 ... enrollment in its randomized, double-blind Phase 2 clinical trial ... as TR-701) in patients with complicated skin and skin ... in 12 clinical sites in the United States, examined ...
... linked to psoriasis ANN ARBOR, Mich., Jan. 25 Scientists ... Dermatology , the U-M School of Public Health ... how genetic differences among individuals result in psoriasis, an autoimmune ... the findings could lead to new drug targets and tailored ...
Cached Medicine Technology:Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections 2Scientists Unmask Genetic Markers Associated With Psoriasis 2Scientists Unmask Genetic Markers Associated With Psoriasis 3Scientists Unmask Genetic Markers Associated With Psoriasis 4
(Date:8/28/2014)... 28, 2014 veEDIS Clinical Systems, ... Information System (EDIS), in Lawrence Medical Center, located ... physicians to document patient care, veEDIS is a ... as well as the authorized, confidential exchange of ... the veEDIS technology, designed in accordance with clinical ...
(Date:8/28/2014)... August 28, 2014 Vitals, a recognized and ... Sabrina Fabi of Cosmetic Laser Dermatology one of their ... thousands of patients to share their doctor experiences and rate ... face time, and follow-ups. The Vitals Top 10 Doctor recognition ... Fabi was ranked one of the highest by patients. , ...
(Date:8/28/2014)... Women must play a greater role in ... on the subject of women and water. Water researcher and ... for Water Partnership and United Nations-Water agree that when water ... Kelly was interviewed by Kleyne on the Sharon Kleyne Hour ... , Kathy Kelly became involved with global water issues as ...
(Date:8/28/2014)... It is not uncommon for people to sink ... Many face ridicule and judgment and find it easier to ... wondering why they keep gaining weight and just cannot seem ... foods, eating more and gaining more, leaving them feeling distain ... has helped thousands safely, successfully and rapidly improve their ...
(Date:8/28/2014)... The Baltimore Business Journal released rankings ... and awarded The Canton Group with the ... design, The Canton Group is the largest firm in ... Fortune 1000, higher education, health care, nonprofits, associations, and ... in web design and web development projects that a ...
Breaking Medicine News(10 mins):Health News:veEDIS Clinical Systems “Delivers,” as the 2014 Edition CEHRT Emergency Department EHR System is Implemented at Lawrence Medical Center 2Health News:veEDIS Clinical Systems “Delivers,” as the 2014 Edition CEHRT Emergency Department EHR System is Implemented at Lawrence Medical Center 3Health News:Dr. Sabrina Fabi of Cosmetic Laser Dermatology Recognized as Vitals Top 10 Doctor 2Health News:Women for Water Partnership and Sharon Kleyne Call for Greater Women’s Role in Global Water Issues 2Health News:Women for Water Partnership and Sharon Kleyne Call for Greater Women’s Role in Global Water Issues 3Health News:Diet Doc’s Medical Weight Loss Programs Announce New Help for Patients Who Want to Overcome Depression Caused by Excess Weight 2Health News:Diet Doc’s Medical Weight Loss Programs Announce New Help for Patients Who Want to Overcome Depression Caused by Excess Weight 3Health News:The Canton Group is Recognized by the Baltimore Business Journal as the Largest Web Design Firm in Baltimore 2
... giving and sharing, St.,David,s Community Health Foundation is delighted ... to area nonprofit organizations that provide,access to health care ... "Especially this year, we are mindful of the ... said Earl Maxwell, CEO of St. David,s,Community Health Foundation. ...
... Abt Associates announced that,Scott W. Royal, Ph.D., M.P.H., ... research programs, has been promoted to Division,Vice President and ... will,oversee the company,s Behavioral Health, Health Policy, and Public ... "We are very pleased that Scott has agreed ...
... one of the nation,s largest and most experienced Medicare contractors, ... joined the company,s board of directors. , ... 30 years of service with the federal agency that manages ... support plan for active-duty service members and retirees, and their ...
... College of Nursing faculty member, Rachel Jones, has been ... of Nursing Research at National Institutes of Health (NIH) to ... designed to reduce HIV sexual risk behavior in young women ... video-capable cell phones. , Jones, assistant professor at the College ...
... Mo. Pregnant women who experience intimate partner ... suffer adverse health effects, including depression, post traumatic ... University of Missouri researchers have found that women ... to seek health care for their infants than ...
... Milk campaign -- famous for,putting white ,staches on some of ... winning and multi-platinum selling artist, Usher, to,turn the creative dreams ... noise? music video program. , ... the chance to flex their,creative muscle by directing and producing ...
Cached Medicine News:Health News:$5.15 Million Provided to Support Local Health Care Needs 2Health News:$5.15 Million Provided to Support Local Health Care Needs 3Health News:$5.15 Million Provided to Support Local Health Care Needs 4Health News:Abt Associates Names Dr. Scott W. Royal to Lead Domestic Health Division 2Health News:Brian Rubin Joins TrailBlazer Health Enterprises' Board of Directors 2Health News:Rutgers College of Nursing faculty member tests cell phone videos to reduce HIV risk 2Health News:Abused women seek more infant health care, MU study finds 2Health News:Usher Teams With Body By Milk to Give Teens Once-in-a-Lifetime Opportunity 2Health News:Usher Teams With Body By Milk to Give Teens Once-in-a-Lifetime Opportunity 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: